Clinical trial Recruiting at 1 site Interventional Ages 18 to 85

Red light treatment for improving blood flow in peripheral artery disease

Official title: Vasodilatory Effects of Light on Peripheral Artery Disease

Run by University of Alabama at Birmingham · NCT03203239 · Data updated 2026-11-12

This study is testing if a short exposure to red light can improve blood flow in the legs of people with peripheral artery disease.

Quick facts

Study typeInterventional
Ages18 Years to 85 Years
SexAll
Enrollment40 (estimated)
SponsorUniversity of Alabama at Birmingham
Academic / other
Locations1 site (Milwaukee, Wisconsin)
StatusRecruiting
StartedJanuary 17, 2018
Main results expectedDecember 31, 2028
Study endsDecember 31, 2028
Registry record updatedMay 1, 2026
Trial IDNCT03203239 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 85 diagnosed with peripheral artery disease, as indicated by an abnormal ankle-brachial index.

Probably not a fit

Patients under 18 or over 85, those with certain medical conditions, or those unable to understand the consent process may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of a single 5-minute exposure to 670 nm red light on blood flow in the gastrocnemius muscle of patients diagnosed with peripheral artery disease. Participants will undergo blood flow measurement using contrast-enhanced ultrasound before and after the light exposure, along with blood samples collected to assess nitric oxide metabolites. The study aims to determine if this non-invasive treatment can enhance vasodilation and improve circulation in affected individuals. It is designed to be completed in one visit, with a possibility of a second visit if data quality requires it.

Why it matters

Potential benefit: If successful, this treatment could provide a novel, non-invasive method to improve blood flow and alleviate symptoms in patients with peripheral artery disease.

How similar studies have gone: While the use of red light therapy is gaining interest, this specific approach in peripheral artery disease is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participants will be subjects between the ages of 18 and 85 who have been diagnosed with peripheral artery disease. Men and women will be recruited for participation. All ethnicities will be included in this study.

Diagnosis of peripheral artery disease is defined as an Ankle Brachial index of \<0.9 or greater than 1.1 either at rest or during treadmill exercise.

Exclusion Criteria:

* Exclusionary criteria include age under 18 years and over 85 years, those who are unable to understand the consent process , those who cannot read or speak English, active pregnancy, hypersensitivity to perflutren contrast agents, pulmonary hypertension, active illicit drug use, untreated blood pressure over 160/95, sickle cell disease, or a history of intracardiac shunt. Additional exclusion criteria neurological diseases such as spinal stenosis, unspecified pain disorders, and any uncontrolled medical conditions.

Where it's running

  • Medical College of Wisconsin
    Milwaukee, Wisconsin, United States
    Recruiting

Study contacts

  • Principal investigator: Nicole L Lohr, MD,PHD — Medical College of Wisconsin
  • Study coordinator: Nicole L Lohr, MD,PHD
  • Email: nlohr@uabmc.edu
  • Phone: 414-996-3504

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.